A level playing field for developing and launching dietary supplements containing cannabis-derived ingredients should come with any decision to deem the substances dietary ingredients, industry stakeholders recommend to the US Food and Drug Administration.
An FDA policy change should include requiring full regulatory compliance by companies already marketing food and supplement products containing hemp and cannabidiol, representatives of vitamin, mineral and supplement
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?